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Abstract 
Hyperlipidaemia is a general term for elevated concentrations of any or all of the lipids in the plasma, 
including hyperlipoproteinemia, hypercholestrimia etc. Hyperlipidaemia is concerned as the cause for coronary 
heart diseases and atherosclerosis which results from slow but sure deposition of lipids in the arteries is a chief 
cause of mortality worldwide. Aim of this study is to evaluate antihyperlipidaemic activity of Chirabilva Ghanavati 
prepared from bark and heart wood of Chirabilva (Holoptelia integrifolia (Roxb.) Planch.). The patients suffering 
from Hyperlipidaemia and its related disorders like non-insulin dependent diabetes etc. were selected randomly and 
divided into two groups, each group contains 15 patients. The patients of group A were advised to take Chirabilva 
Ghanavati prepared from stem bark. The patients of group B were advised to take Chirabilva Ghanavati prepared 
from heart wood. The overall result showed that Chirabilva Ghanavati prepared from the stem bark was more 
effective than Chirabilva Ghanavati prepared from the heart wood in Hyperlipidaemia. 
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Introduction 
Ayurveda descended on the earth more than 
three millenniums ago, with the great tapas, made by 
seers like Bharadvaja for the welfare of the mankind. 
(1) The main utility of Ayurveda is- 
 To maintain the health of the healthy individual 
and 
 To cure the disease of a patient (2)  
 
For the maintenance of the health of a healthy 
individual, there are many things described in 
Ayurveda such as Dinacharya, Ritucharya, 
Quantitative dietetics, Qualitative dietetics, 
Swasthavritta, Sadavritta etc. If a healthy individual 
fails to follow these things, then he may suffer from 
several diseases as in the case of Medovriddhi. 
 Absence of physical activity, sleeping 
during day and intake of foods which increase Kapha, 
make the end product of digestion (abnormally) sweet 
which in turn causes increase of Medas (fats). This 
increased Medas obstructs the nutrient channels of 
remaining tissues depriving them of nutrition. (3) Fat 
accumulated in large quantity in the body leads to 
Abaddha Medovriddhi or Hyperlipidaemia. 
Today is the era of modernization and fast life. 
Everybody is busy and leading a stressful life. 
Consumption of fast foods having high calorific value 
is also increasing. People have every comfort of living 
and they are not doing any kind of physical activity and 
so the body fats along with cholesterol are increasing in 
their body, which invites the disorders like 
Hypertension, Heart diseases and Hyperlipidaemia. (4) 
The industrialization, stress during the work, 
dietary habits, lack of exercise and intake of various 
varieties of junk food among the daily diet e.g. fast 
food, frozen fruits, increased amount of soft drinks and 
beverages, canned foods results into the disturbance of 
Agni or metabolism and ultimately leads to clinical 
entity known as Hyperlipidaemia. (4) 
Hyperlipidaemia is a general term for elevated 
concentrations of any or all of the lipids in the plasma, 
including hyperlipoproteinemia, hypercholesterolemia, 
etc. (5) Hyperlipidaemia is concerned as the cause for 
coronary heart diseases and atherosclerosis which 
results from slow but sure deposition of lipids in the 
arteries is a chief cause of mortality worldwide. (6) 
Coronary Heart Disease (CHD) is the number 
one killer among the diseases and it accounts for 37% of 
adult deaths in the US every year. (7) Nikolai Anichkov 
in 1912 discovered the role of cholesterol in CHD, 
currently the world’s most deadly disease. (8) CHD is 
the commonest cause of death in the UK. Average level 
of cholesterol is 12% higher in the UK population than 
in the USA and 80% of UK adults have a total 
cholesterol level above 200mg/dl. In India, persons 
suffering from the CHD are doubled in the last 20 years. 
(9) In South India, CHD incidences are 7.4% in rural 
area and 13.9% in urban area, which is higher than 
North India (Rural- 3% and urban 9.7%). (10) Mortality 
from cardiovascular disorders in India is 430/100000 in 
both sexes and in males it is 460 whereas in females it 
accounts for 400/100000 deaths per year. (11) The 
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mean cholesterol in urban India is 190mg/dl whereas in 
rural area it is 150mg/dl. (12) Raised Cholesterol (>220 
mg/dl) is prevalent in 60% population of 50-59 years 
age group and 55% population in 60-100 years age 
group in females in India whereas in males it is 
prevalent in 45% individuals of 40-49 years age group. 
(13) From point of view of High-density lipoproteins 
(HDL), 28.2% males and 12.9% females have HDL 
below 1 mmol/L. (14) Punjab state has the highest 
population suffering from heart disorders including 
ischemic heart disease (IHD) and Hypertension (HT). 
 
Aims and Objectives 
To evaluate antihyperlipidaemic activity of 
Chirabilva Ghanavati prepared from bark and heart 
wood of Chirabilva (Holoptelia integrifolia (Roxb.) 
Planch.). 
 
Materials and Methods 
Selection of Patients  
 Persons suffering from dyspnoea on exertion, 
weight gain, obesity, diabetes mellitus and 
hypertension were screened for Hyperlipidaemia. 
 As the hyperlipidemic state is leading to many of 
the above said conditions, such patients were 
selected for the experimental trial. 
 The cases were registered from the O.P.D. of the 
S.V. Ayurvedic College/ Hospital and were 
selected for the study. 
 
Praparation of Medicine 
Collection of drug 
The stem bark and heart wood of the drug 
Chirabilva was collected from the natural sources in 
and around Tirupati. The bark and heart wood were then 
thoroughly cleaned, cut into pieces, dried and 
powdered. 
 
Preparation of Kashaya 
In order to prepare medicine, first Kashaya was 
made. The ratio of drug and water was 1: 16. The 
powdered bark and heart wood were then weighed and 
16 times water was added separately to them and was 
boiled till it got reduced to ¼ th. The filtered part, 
known as Kashaya, was prepared from both the part 
separately. 
Weight of the drug (Heart wood or bark)  - 16 kg 
Water  - 256 litres 
Reduced to ¼ th i.e.  - 64 litres 
 
Preparation of Rasakriya 
Thus the obtained Kashaya was filtered through 
a cloth and then it was made into Rasakriya. 
According to the principle, 
 
Kwathadinampunah pakatghantvamsararasakriya. 
(15)  
The Kashaya was again boiled and after it 
attained a semisolid consistency, it was further heated 
and after it got dried it was scraped out of the boiler. 
 
 
Preparation of granules 
The obtained material was put inside the 
granule making machine and granules of the scraped 
material was obtained. 
 
Preparation of tablets 
 Talc was added to it and further it was put into 
tablet making machine and tablets weighing 
500mg were prepared. 
 The said procedure was conducted at Srinivasa 
Ayurveda Pharmacy, Srinivasa Mangapuram, 
Tirupati. 
 The above procedure was undertaken to avoid 
difficulty in administration of the drug to patients 
on OP basis. 
 The patients were given a packet of medicine 
with 60 tablets in it. 
 
Rationality of selecting the drug:  
 Acharya Charak has mentioned under Lekhaniya 
Mahakashaya. (16) 
 Easily available. 
 Cheap 
 No previous work was found on its heart wood. 
 Most of the previous works are done on bark and 
leaves as an anti-inflammatory, analgesic, on 
piles, on diabetes etc.. 
 Modern anti-hyperlipidaemics like statins are 
found to have many adverse reactions; 
   
 Hence it is the need of the hour to find an 
alternative drug in other systems of medicine. So in the 
present study Chirabilva Ghanavati was taken as a test 
drug in Hyperlipidemia. 
 
Inclusion criteria 
Patients suffering from Hyperlipidaemia and its 
related disorders like non-insulin dependent diabetes in 
the age group of 30-60 years. 
 
Exclusion criteria 
 Patients below 30 years and above 60 years of 
age. 
 Patients suffering from Insulin-Dependent 
Diabetes Mellitus (I.D.D.M.), severe diabetes 
mellitus with complications, malignant disorders 
and renal disorders. 
 Patients who have a previous history of cardiac 
or cerebral stroke and also in patients who 
underwent by-pass surgery. 
 
Pathological investigations 
Following investigations will be carried out 
before and after treatment. 
 Hematological investigations – Hemoglobin 
(Hb), Total Leukocyte Count (TLC), Differential 
Leukocyte Count (DLC), Erythrocyte 
Sedimentation Rate (ESR). 
 Urine analysis –Routine and Microscopic. 
 Biochemical examinations - Post-Prandial Blood 
Sugar (PPBS), Fasting Blood Sugar (FBS), Lipid 
profile. 
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Diagnostic criteria 
 Patients were diagnosed on the basis of Lipid 
Profile. Any one or more of the following criteria were 
selected. 
 Serum cholesterol (201 mg/dl or more) 
 Serum Triglycerides (151 mg/dl or more) 
 High-density lipoproteins (HDL) <35 mg/dl 
 
Grouping 
The patients suffering from Hyperlipidaemia 
and its related disorders were selected randomly and 
divided into two groups. 
1.  Group –A: The patients of group A were 
advised to take Chirabilva Ghanavati prepared from 
stem bark 
2.  Group-B: The patients of group Bwere 
advised to take Chirabilva Ghanavati prepared from 
heart wood. 
 
Follow Up: 
After completion of the treatment, the patients 
of both the groups have been examined during follow 
ups at the interval of two weeks. 
 
Duration of treatment 
The course of the treatment was fixed as 45 
days. The patients were instructed to avoid diet which 
can increase fat like oily food, butter, eggs, meat etc. 
Preliminary data was collected before treatment. 
 
Dose  
The patients were given 4 tablets (each tablet 
weighing 500 mg) per day, 2 tablets in the morning and 
2 tablets in the evening with water. 
 
Plan of data analysis 
The data according to parameters (lipid profile) 
were validated and subjected for statistical evaluation 
and significance of result is mentioned according to ‘P’ 
value. The overall result is mentioned according to 
percentage of relief and relief in number of parameters. 
If all five parameters comes within normal range, the 
result is considered as ‘Completely relieved’; if four 
parameters comes within normal range, the result is 
considered as ‘Markedly relieved’; if three parameters 
comes within normal range, the result is considered as 
‘Moderately relieved’; if two or only one parameters 
become within normal range, the result is considered as 
‘Mildly relieved’ and if no parameter come within 
normal range, the result is considered as ‘Unchanged’. 
The normal values of parameters are given below- 
 
Table No. 1: Normal values of lipid profile [17] 
 
Total Cholesterol 
< 200 → Desirable 
200-239 → Borderline 
≥240 → High 
LDL 
< 100 →Optimal 
100-129 → Near optimal 
130-159 → Borderline 
160-189→ High 
≥ 190 → Very High 
VLDL 
<32→ Desirable 
HDL 
< 40 → Low 
≥ 60 → High 
Serum Triglycerides 
< 150 → normal 
150-199 → Borderline 
200-499 → High 
≥ 500 → Very High 
Observations and results: 
Table No. 2: EFFECT OF MEDICINE ON LIPID PROFILE OF GROUP A PATIENTS  
 
(n=15, df=14) 
The P value of all the parameters were below 0.05, hence the results of treatment were very significant. 
Parame
ters 
  
Mean 
(mg/dl) Mean 
diff. 
S.D. S.E. 
‘t’ P Significance 
B.T. A.T. B.T. A.T. B.T. A.T. 
T.C. 214.32 163.64 50.68 31.37 11.06 8.10 2.856 6.6309 < 0.0001 
Extremely 
significant 
L.D.L. 140.47 95.60 44.87 37.84 10.62 9.77 2.74 5.1096 0.0002 
Extremely 
significant 
H.D.L. 36.13 40.94 -5.80 2.70 5.05 0.70 1.26 5.9079 <0.0001 
Extremely 
significant 
V.L.D.L 37.72 26.107 11.61 9.28 3.78 2.39 0.97 5.3365 0.0001 
Extremely 
significant 
T.G. 188.60 130.53 58.07 46.42 18.90 11.99 4.88 5.3365 0.0001 
Extremely 
significant 
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Graph No. 1: EFFECT OF MEDICINE ON LIPID PROFILE OF GROUP A PATIENTS 
 
 
TABLE No. 3: EFFECT OF MEDICINE ON LIPID PROFILE OFGROUP B PATIENTS  
 
(n=15, df=14) 
The P value of all the parameters were below 0.05, hence the results of treatment were very significant. 
 
Graph No. 2: EFFECT OF MEDICINE ON LIPID PROFILE OFGROUP B PATIENTS 
 
 
 
 
Paramet
ers 
  
Mean 
(mg/dl) 
Mean 
diff. 
S.D. S.E. 
‘t’ P 
Signifi
cance 
B.T. A.T. B.T. A.T. B.T. A.T. 
T.C. 220.73 181.60 39.13 28.60 13.46 7.38 3.47 5.7928 < 0.0001 
Extrem
ely 
signifi
cant 
L.D.L. 145.13 103.93 41.20 31.73 10.89 8.19 2.81 4.7567 < 0.0001 
Extrem
ely 
signifi
cant 
H.D.L. 36.60 41.93 -5.33 2.41 5.85 0.62 1.51 3.2644 0.0029 
Very 
signifi
cant 
V.L.D.L. 38.60 35.73 2.87 4.56 2.63 1.18 0.68 2.9693 0.0102 
Signifi
cant 
T.G. 193.27 179.53 13.73 23.25 12.88 6.00 3.33 2.7596 0.0154 
Signifi
cant 
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OVERALL RESULT OF STUDY- 
 
TABLE No. 4: EFFECT OF MEDICINE ON GROUP ‘A’ PATIENTS 
 
 
Graph No. 3: EFFECT OF MEDICINE ON GROUP ‘A’ PATIENTS 
 
Out of 15 patients 53.33 % patients got completely relief, 26.67 % patients got marked relief, 13.33 % patients got 
moderate relief and 06.67 % patients got mild relief. 
 
TABLE No. 5: EFFECT OF MEDICINE ON GROUP ‘B’ PATIENTS  
 
 
Graph No. 4: EFFECT OF MEDICINE ON GROUP ‘B’ PATIENTS 
 
 
Out of 15 patients 06.67% patients got completely relief, 46.66 % patients got marked relief, 40.00% patients got 
moderate relief and 06.67 % patients got mild relief. 
Result No. of Patients % of patients 
Completely Relieved 8 53.33 
Markedly Relieved 4 26.67 
ModeratelyRelieved 2 13.33 
MildlyRelieved 1 06.67 
Unchanged 0 0 
Result No. of Patients % of patients 
Completely Relieved 1 06.67 
Markedly Relieved 7 46.66 
Moderately Relieved 6 40.00 
Mildly Relieved 1 06.67 
Unchanged 0 0 
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OVERALL EFFECT OF MEDICINE ON GROUP ‘A’ & GROUP ‘B’ PATIENTS 
TABLE No. 6: OVER ALL EFFECT
 
(* Negative sign in % of relief for HDL shows percentage of increase) 
 
Graph No. 5: OVER ALL EFFECT 
 
The overall result showed that the medicine used for group A patients was more effective than the medicine used for 
group B patients. 
S.N. CHANGE IN 
PARAMETERS* 
% OF RELIEF 
GROUP A GROUP B 
1. TOTAL CHOLESTROL 23.64 16.66 
2. LDL 31.95 25.42 
3. HDL -16.05 -14.84 
4. VLDL 30.78 06.45 
5. TRIGLYCERIDES 30.79 06.07 
Discussion 
Effect of Therapies:  
 The effect of therapy on group A patients shows 
that 53.33% patients got completely relief, 26.67 % 
patients got marked relief, 13.33% patients got moderate 
relief and 06.67 % patients got mild relief and the effect 
of therapy on group B patients shows that 06.67% 
patients got completely relief, 46.66 % patients got 
marked relief, 40.00% patients got moderate relief and 
06.67 % patients got mild relief. 
 
Overall effect of medicine:  
 The total cholesterol level of group A patients 
was reduced by 23.64 % while of group B patients was 
reduced by 16.66 %. The L.D.L. level of group A 
patients was reduced by 31.95 % while of group B 
patients was reduced by 25.42 %. The H.D.L. level of 
group A patients was increased by 16.05 % while of 
group B patients was increased by 14.84 %. The 
V.L.D.L. level of groupA patients was reduced by 30.78 
% while of group B patients was reduced by 06.45%. 
The triglycerides level of group A patients was reduced 
by 30.79 % while of group B patients was reduced by 
06.07%. All the results were statistically significant 
(P<0.05). 
 
Probable mode of action of drug:   
 Chirabilva is the drug having Tikta, Kashaya 
Rasa; Laghu, Ruksha Guna; Usna Virya; and Katu 
Vipaka. It acts on Meda by its Lekhana, Medohara 
Karma. Due to its Katu, Tikta Rasa it acts as Meda 
Upashoshaka. Tikta Rasa also acts as Upashoshaka of 
Vasa, Majja etc. Due to Laghu and Ruksha Gunas, it is 
reducing the excess of Abaddha Medas i.e. freely 
flowing fats in the circulation. 
 
Conclusion 
Chirabilva, one of the important drugs of 
Lekhaniya Dashemani, was taken as a trial drug to 
evaluate its anti hyperlipidaemic activity. 
Almost all Acharyas have mentioned Katu, Tikta 
Rasa; Laghu, Tikshna Guna; Usna Virya; Katu Vipaka 
for Chirabilva. 
The patients of group A were treated with 
Chirabilva Ghanavati prepared from the stem bark and 
the patients of group B were treated with Chirabilva 
Ghanavati prepared from the heart wood. 
On clinical examination it was found that out of 
15 patients (Group A) 53.33% patients got complete 
relief, 26.67 % patients got marked relief, 13.33% 
patients are moderate relief and 06.67 % patients got 
mild relief after taking Ghanavati prepared from the 
stem bark. 
Out of 15 patients (Group B) 06.67% patients 
got complete relief, 46.66 % patients got marked relief, 
40.00% patients got moderate relief and 06.67 % 
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patients got mild relief after taking Ghanavati prepared 
from the heart wood. 
The overall result showed that Chirabilva 
Ghanavati prepared from the stem bark was more 
effective than Chirabilva Ghanavati prepared from the 
heart wood in Hyperlipidaemia. 
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